- Home
- DBVT vs FTHM Comparison
DBVT vs FTHM Comparison
Compare DBVT & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- FTHM
- Stock Information
- Founded
- DBVT 2002
- FTHM 2010
- Country
- DBVT France
- FTHM United States
- Employees
- DBVT N/A
- FTHM N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- FTHM Real Estate
- Sector
- DBVT Health Care
- FTHM Finance
- Exchange
- DBVT Nasdaq
- FTHM Nasdaq
- Market Cap
- DBVT 434.7M
- FTHM 38.3M
- IPO Year
- DBVT N/A
- FTHM 2020
- Fundamental
- Price
- DBVT $15.65
- FTHM $1.78
- Analyst Decision
- DBVT Buy
- FTHM Strong Buy
- Analyst Count
- DBVT 4
- FTHM 1
- Target Price
- DBVT $14.81
- FTHM $2.50
- AVG Volume (30 Days)
- DBVT 114.2K
- FTHM 637.0K
- Earning Date
- DBVT 11-05-2025
- FTHM 11-06-2025
- Dividend Yield
- DBVT N/A
- FTHM N/A
- EPS Growth
- DBVT N/A
- FTHM N/A
- EPS
- DBVT N/A
- FTHM N/A
- Revenue
- DBVT $3,800,000.00
- FTHM $390,032,000.00
- Revenue This Year
- DBVT $1,743.46
- FTHM $25.22
- Revenue Next Year
- DBVT $1,044.34
- FTHM $16.19
- P/E Ratio
- DBVT N/A
- FTHM N/A
- Revenue Growth
- DBVT N/A
- FTHM 19.16
- 52 Week Low
- DBVT $2.21
- FTHM $0.65
- 52 Week High
- DBVT $16.98
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- DBVT 71.91
- FTHM 47.09
- Support Level
- DBVT $14.63
- FTHM $1.54
- Resistance Level
- DBVT $16.90
- FTHM $1.78
- Average True Range (ATR)
- DBVT 1.20
- FTHM 0.15
- MACD
- DBVT 0.55
- FTHM -0.04
- Stochastic Oscillator
- DBVT 82.65
- FTHM 36.30
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.